IMS Health & Hootsuite Form Alliance to Help Life Sciences Companies Increase Engagement on Social Media Channels & Support C...
March 16 2016 - 11:01PM
Business Wire
Integration Drives More Effective Social
Interactions with Patients and Healthcare Providers
IMS Health (NYSE:IMS) today announced the launch of the IMS
Health AETracker application for Hootsuite — a first-of-its-kind
offering that enables life sciences companies to drive compliance
and engagement with patients and healthcare providers on social
media channels. The new app is available on the Hootsuite App
Directory and integrates AETracker — IMS Health’s advanced
technology solution for identifying, tracking and reporting adverse
events, product complaints and off-label usage in real time — with
the Hootsuite platform, the most widely used solution for managing
social media.
Every life sciences company has multiple forums and “touch
points” where patients and healthcare providers share their
experiences, ask questions and discuss possible side effects
related to their medications. With only a narrow window in which to
report adverse events to government regulators, it can be
challenging for companies to continuously monitor the vast
quantities of data flowing through these enterprise-sponsored
accounts on Facebook, Twitter and other social channels. The IMS
Health AETracker application for Hootsuite supports client efforts
to stay in compliance in markets worldwide.
AETracker’s real-time risk detection and 24/7 IMS Health Social
Command Center is accessible in the Hootsuite dashboard, which
provides clear visualization of social media insights through an
easy-to-use engagement console. The integration alleviates the
compliance burden for life sciences companies — enabling their
marketing employees and agencies to focus on meaningful, efficient
engagement with patients and healthcare providers.
As part of IMS Health’s Nexxus™ Commercial Application Suite,
AETracker is a best-in-class SaaS solution that uses patent-pending
algorithms to detect possible adverse events in unstructured data
across social media channels, mobile health applications and
branded websites. Hootsuite’s highly intuitive dashboard empowers
life sciences companies to consolidate multiple social channels
into one comprehensive view — enabling efficient tracking and
response to patients’ and healthcare providers’ comments, questions
and requests.
“The integration of the IMS Health AETracker application with
Hootsuite makes it easier than ever for our clients to realize the
benefits of AETracker,” said Siva Nadarajah, general manager,
social media, Technology Solutions, IMS Health. “With Hootsuite’s
easy-to-use platform, users can achieve a higher level of social
media engagement while also addressing the critical need to detect
and report adverse events and other regulatory compliance risks in
a timely way.”
IMS Health’s Social Command Center is staffed by certified
healthcare professionals who evaluate potential threats and trigger
reporting usually within an hour of detection by the
solution. Additionally, the command center assists with
product complaints and off-label risks that could appear in social
media conversations.
“The IMS Health AETracker app will be a valuable addition to our
ecosystem of best-of-breed partners. Hootsuite is seeing
significant growth in both the Healthcare and Pharmaceutical
industries, and effective, compliant patient engagement is crucial
to healthcare providers. IMS Health's industry expertise, global
reach and reputation are very complementary and we look forward to
a long mutually beneficial relationship," said Cameron Burke,
director of Solution Partners at Hootsuite.
The Nexxus Commercial Application Suite brings together the most
complete and fully connected set of life sciences applications
across the commercial continuum, from marketing campaign management
and social media monitoring to customer engagement, sales
operations and performance management.
Hootsuite is the most widely used platform for managing social
media, with more than 12 million users including 800 of the Fortune
1000 companies. Hootsuite’s App Directory, the leading app market
place for social media management, brings together more than 150
best-of-breed integrations and business applications.
IMS Health announced this integration from the eyeforpharma
conference in Barcelona, Spain. For more information on the
AETracker application for Hootsuite, visit the IMS Health exhibit
area (#41–46).
About IMS Health
IMS Health is a leading global information and technology
services company providing clients in the healthcare industry with
end-to-end solutions to measure and improve their performance. Our
7,500 services experts connect configurable SaaS applications to
10+ petabytes of complex healthcare data in the IMS One™ cloud
platform, delivering unique insights into diseases, treatments,
costs and outcomes. The company’s 15,000 employees blend global
consistency and local market knowledge across 100 countries to help
clients run their operations more efficiently. Customers include
pharmaceutical, consumer health and medical device manufacturers
and distributors, providers, payers, government agencies,
policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available at
www.imshealth.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160316006594/en/
IMS HealthTor Constantino, +1 484-567-6732Media
Relationstconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jul 2023 to Jul 2024